Table 2.
Treatment | Fish | Cumulative Mortality | RPS | χ2 | P-value |
---|---|---|---|---|---|
RBT-1 | |||||
pcDNA | 29 | 62.1% | |||
pVHSivb-G | 26 | 26.9% | 56.7% | 6.83 | 0.009 |
pVHSivb-G (2 doses) | 13 | 15.4% | 75.2% | 7.84 | 0.005 |
RBT-2 | |||||
pcDNA | 35 | 8.6% | |||
pVHSivb-G | 17 | 0.0% | 100.0% | 1.55 | 0.214 |
pVHSivb-G (2 doses) | 31 | 0.0% | 100.0% | 2.78 | 0.095 |
BNT-1 | |||||
pcDNA | 26 | 23.1% | |||
pVHSivb-G | 38 | 5.3% | 77.2% | 4.48 | 0.034 |
pVHSivb-G (2 doses) | 18 | 16.7% | 27.8% | 0.27 | 0.604 |
BNT-2 | |||||
pcDNA | 28 | 10.7% | |||
pVHSivb-G | 25 | 4.0% | 62.7% | 0.85 | 0.356 |
pVHSivb-G (2 doses) | 25 | 4.0% | 62.7% | 0.85 | 0.356 |
LAT-1 | |||||
pcDNA | 26 | 30.7% | |||
pVHSivb-G | 34 | 0.0% | 100.0% | 12.07 | 0.0005 |
pVHSivb-G (2 doses) | 27 | 0.0% | 100.0% | 9.79 | 0.0018 |
LAT-2 | |||||
pcDNA | 26 | 34.6% | |||
pVHSivb-G | 34 | 0.0% | 100.0% | 13.85 | 0.0002 |
pVHSivb-G (2 doses) | 27 | 0.0% | 100.0% | 11.26 | 0.0008 |
Rainbow trout (RBT-1 and RBT-2), brown trout (BNT-1 and BNT-2) and lake trout (LAT-1 and LAT-2) vaccine trials. Table includes the number of fish in each treatment, the cumulative mortality and the relative percent survival (RPS) and the associated P-value calculated using a two-tailed χ2-test